Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target
Repurposing the large arsenal of existing non‐cancer drugs is an attractive proposition to
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
[PDF][PDF] Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target
S Islam, S Wang, N Bowden, J Martin, R Head - 2021 - scienceopen.com
Cancer is one of the most pressing health challenges, being the second leading cause of
death worldwide. In 2018, 18.0 million people were diagnosed with cancer leading to 9.6 …
death worldwide. In 2018, 18.0 million people were diagnosed with cancer leading to 9.6 …
[HTML][HTML] Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target
S Islam, S Wang, N Bowden, J Martin… - British Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Repurposing the large arsenal of existing non‐cancer drugs is an attractive proposition to
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
S Islam, S Wang, N Bowden, J Martin… - British Journal of Clinical …, 2021 - europepmc.org
Repurposing the large arsenal of existing non‐cancer drugs is an attractive proposition to
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target
S Islam, S Wang, N Bowden… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Repurposing the large arsenal of existing non-cancer drugs is an attractive proposition to
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
S Islam, S Wang, N Bowden… - British Journal of …, 2022 - search.ebscohost.com
Repurposing the large arsenal of existing non‐cancer drugs is an attractive proposition to
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …